Bjorn H. Ruter

Biberach An Der Riss, BW, DE 
Biberach An Der Riss, BW, DE 

Overview

Bjorn Ruter practices practicing medicine in Biberach An Der Riss, Germany.

Their clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Smith-Magenis Syndrome, and Myelodysplastic Syndrome (MDS).

They are actively involved in clinical research, co-authoring 11 peer reviewed articles.

Locations

Biberach An Der Riss, BW, Germany
Other Locations
Freiburg, BW 79106, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Total Publications

An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemia.
An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemia.
Journal: Haematologica
Published: March 31, 2022

Frequently Asked Questions about Bjorn H. Ruter

Is Bjorn H. Ruter a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Bjorn H. Ruter is classified as an Experienced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Bjorn H. Ruter participate in research or clinical trials?

Yes. Bjorn H. Ruter has published 11 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Bjorn H. Ruter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ruter's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile